Spiriva Capsules ; Out-of-specification (uniformity Of Delivered Dose)

Spiriva 18mcg capsules are being recalled in Canada due to a quality issue where the amount of medication delivered may not be consistent from capsule to capsule. This recall affects all Spiriva 18mcg capsules distributed across Canada. This is classified as a Class III recall, which is a lower-risk category.

Product

Spiriva 18mcg capsule

Reason

Product quality concern

Classification

Class III

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2026-06-25

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/38477753-2052-4e13-bb0e-c2219ad6aa22